𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dendritic cells in cancer immunotherapy

✍ Scribed by Gerold Schuler

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
212 KB
Volume
40
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Monitoring of circulating angiogenic fac
Monitoring of circulating angiogenic factors in dendritic cell–based cancer immunotherapy
✍ Christine Brostjan; Anita Bayer; Anna Zommer; Alexander Gornikiewicz; Sebastian πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 147 KB

## Abstract ## BACKGROUND A promising treatment approach for patients with malignant disease that recently has found its way into clinical trials is based on vaccination with autologous dendritic cells loaded with tumor antigens. However, adequate assays for monitoring clinical and immunologic res

Stimulatory effects of CpG oligodeoxynuc
Stimulatory effects of CpG oligodeoxynucleotide on dendritic cell-based immunotherapy of colon cancer in CEA/HLA-A2 transgenic mice
✍ Asim Saha; Malaya Bhattacharya-Chatterjee; Kenneth A. Foon; Esteban Celis; Sunil πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 250 KB

## Abstract Immunostimulatory DNA containing unmethylated cytosine‐guanine (CpG) motifs have been successfully used as adjuvants to enhance the immunity of vaccines designed to trigger antitumor T‐cell responses. We examined the effect of a CpG oligodeoxynucleotide (CpG ODN) for its ability to pote

Immunotherapy with dendritic cells and C
Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer
✍ Carole Bourquin; Susanne Schreiber; Sebastian Beck; Gunther Hartmann; Stefan End πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 French βš– 218 KB

## Abstract Although immunotherapy has shown promising results in the treatment of cancer, clinical studies assessing immunologic approaches in patients with advanced cancer will seldom be conducted in the absence of conventional treatment strategies such as chemotherapy. Here we investigate the co

Immunotherapy with dendritic cells for p
Immunotherapy with dendritic cells for prostate cancer
✍ Anna-Katharina Thomas-Kaskel; Cornelius F. Waller; Wolfgang Schultze-Seemann; He πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 French βš– 152 KB

## Abstract Radical prostatectomy for prostate cancer is followed by PSA recurrence in up to 40% of patients. One third of patients with biochemical relapse progress to uncurable metastatic disease. Therefore, alternative treatment modalities are needed both in the situation of PSA recurrence and i

Lentivirally transduced dendritic cells
Lentivirally transduced dendritic cells as a tool for cancer immunotherapy
✍ Karine Breckpot; Melissa Dullaers; Aude Bonehill; Sonja Van Meirvenne; Carlo Hei πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 348 KB

## Abstract ## Background Dendritic cells (DC) are the professional antigen‐presenting cells of the immune system, fully equipped to prime naive T cells and thus essential components for cancer immunotherapy. ## Methods We tested the influence of several elements (cPPT, trip, WPRE, SIN) on the t